NIAID has been at the forefront of cutting-edge biomedical research for decades. The work performed in its labs has furthered the understanding of the immune system and led to significant advances in the fields of immunology and infectious disease research. But it's a long path from basic scientific discoveries to approved vaccines, treatments, or diagnostic tools. NIAID is constantly pursuing collaborations with industry and academia to develop its technologies and materials into products that improve public health. The NIAID Technology Transfer and Intellectual Property Office (TTIPO) facilitates collaborative relationships between NIAID investigators and the broader scientific community.
Last Updated June 29, 2012
Last Reviewed June 29, 2012